RSC Advances
Paper
(m, 2H), 4.21–4.26 (m, 2H). 13C-NMR (150 MHz, CDCl3): d/ppm
22.9, 28.9, 29.3, 34.5, 69.2, 176.4.
Oxidation of ketones in the presence of ionic liquids. Into
a two-necked round-bottomed ask equipped with a septum,
a condenser with a balloon lled with nitrogen, and a magnetic
stirring bar, a ketone (0.094–0.234 g, 1.34 mmol) and ionic
liquid (0.470–0.942 g, 1.34 mmol) were placed. Then, 30% aq.
H2O2 (0.304 g, 2.68 mmol) was slowly added into the ask using
a syringe. Aer the reaction completion (1–120 min), 2 cm3 of
water and 2 cm3 of dichloromethane were added, and stirred
vigorously (5 min). The organic phase was analysed by GC with
decane as an internal standard. For the isolation of product, the
reaction mixture was dissolved in water (2 cm3), extracted with
dichloromethane (6 ꢂ 5 cm3) and concentrated. The yields of
lactones aer the purication using column chromatography
with a short bed of Al2O3 (the conversion of ketone was 100%,
and only the isolation of traces of ionic liquid was necessary)
and dichloromethane as the eluent were 89–93%. 4-Oxatricyclo
[4.3.1.13.8]undecan-5-one was isolated by the extraction of the
post reaction mixture with toluene (10 ꢂ 2 cm3). Aer vacuum
drying, the lactone was puried by crystallisation from hexane–
ethyl acetate. The structure and purity of all synthesised ketones
and lactones were conrmed by 1H and 13C NMR analysis (ESI)
and were essentially identical with published spectral data for
authentic samples:
4-Methyl-3-caprolactone.21 (1H-NMR, 300 MHz, CDCl3, TMS): d/
ppm 0.94 (d, J ¼ 6.6 Hz, 3H), 1.80–1.92 (m, 5H), 2.55–2.71 (m,
2H), 4.15–4.25 (m, 2H). 13C-NMR (75 MHz, CDCl3): d/ppm 18.8,
21.6, 34.2, 36.7, 40.2, 67.5, 175.5.
4-Ethyl-3-caprolactone.22 (1H NMR, 600 MHz, CDCl3, TMS): d/
ppm 0.92 (t, J ¼ 7.5 Hz, 3H), 1.40–1.28 (m, 3H), 1.57–1.43 (m,
2H), 1.93 (dddt, J ¼ 15.1, 7.5, 3.6, 2.0 Hz, 1H), 2.03–1.96 (m, 1H),
2.61 (ddd, J ¼ 14.1, 12.4, 2.1 Hz, 1H), 2.69 (ddd, J ¼ 14.1, 7.6, 1.7
Hz, 1H), 4.18 (dd, J ¼ 12.8, 10.1 Hz, 1H), 4.31 (ddd, J ¼ 12.7, 5.9,
1.6 Hz, 1H). 13C NMR (150 MHz, CDCl3): d/ppm 11.14, 28.38,
28.98, 33.02, 34.83, 41.73, 68.05, 176.01.
4-Propyl-3-caprolactone.22 (1H NMR, 600 MHz, CDCl3, TMS): d/
ppm 0.90 (t, J ¼ 7.2 Hz, 3H), 1.38–1.22 (m, 6H), 1.53–1.44 (m,
1H), 1.67–1.57 (m, 2H), 1.92 (dddd, J ¼ 16.0, 7.6, 3.8, 1.9 Hz, 1H),
2.01–1.95 (m, 1H), 2.61 (ddd, J ¼ 14.1, 12.3, 2.1 Hz, 1H), 2.68
(ddd, J ¼ 14.0, 7.6, 1.7 Hz, 1H), 4.18 (dd, J ¼ 12.9, 10.4 Hz, 1H),
4.30 (ddd, J ¼ 12.9, 6.0, 1.8 Hz, 1H). 13C NMR (150 MHz, CDCl3):
d/ppm 13.97, 19.70, 28.74, 33.04, 35.20, 38.50, 39.75, 68.05,
176.08.
4-tert-Butyl-3-caprolactone.23 (1H NMR, 600 MHz, CDCl3, TMS)
d/ppm 0.90 (s, 9H), 1.41–1.30 (m, 2H), 1.57–1.47 (m, 1H), 2.11–
1.99 (m, 2H), 2.62–2.53 (m, 1H), 2.71 (ddd, J ¼ 14.2, 7.5, 1.2 Hz,
1H), 4.16 (dd, J ¼ 12.9, 10.5 Hz, 1H), 4.34 (ddd, J ¼ 12.9, 6.0, 1.8
Hz, 1H). 13C NMR (150 MHz, CDCl3): d/ppm 23.76, 27.43, 30.33,
32.98, 33.45, 50.77, 68.62, 176.29.
3-Phenylcyclobutanone.18 (1H-NMR, 300 MHz, CDCl3, TMS):
d/ppm 3.22–3.27 (m, 2H), 3.44–3.50 (m, 2H), 3.66 (quint., J ¼
8.2 Hz, 1H), 7.20–7.38 (m, 5H). 13C-NMR (75 MHz, CDCl3): d/
ppm 31.1, 57.4, 129.2, 129.3, 131.4, 146.3, 209.2.
4-Phenyl-3-caprolactone.24 (1H NMR, 600 MHz, CDCl3, TMS): d/
ppm 1.89–1.80 (m, 1H), 2.11–1.99 (m, 2H), 2.17–2.11 (m, 1H),
2.88–2.73 (m, 3H), 4.32 (dd, J ¼ 12.8, 10.3 Hz, 1H), 4.39 (ddd, J ¼
13.0, 5.5, 2.0 Hz, 1H), 7.17–7.20 (m, 2H), 7.25–7.21 (m, 1H),
7.34–7.30 (m, 2H). 13C NMR (150 MHz, CDCl3): d/ppm 30.33,
33.69, 36.75, 47.25, 68.20, 126.57, 126.84, 128.75, 144.92,
175.58.
3-Butylcyclobutanone.18 (1H-NMR, 300 MHz, CDCl3, TMS): d/
ppm 0.92 (t, J ¼ 6.8 Hz, 3H), 1.20–1.40 (m, 4H), 1.55–1.62 (m,
1H), 2.28–2.43 (m, 1H), 2.50–2.70 (m, 2H), 3.10–3.19 (m, 2H).
13C-NMR (75 MHz, CDCl3): d/ppm 13.9, 22.4, 23.8, 30.4, 35.9,
52.4, 208.6.
3-Phenyl-g-butyrolactone.18 (1H NMR, 300 MHz, CDCl3, TMS):
d/ppm 2.66 (dd, J ¼ 17.5 Hz, 9.1 Hz, 1H), 2.92 (dd, J ¼ 17.5 Hz,
8.1 Hz, 1H), 3.77 (quint., J ¼ 8.4 Hz, 1H), 4.26 (dd, J ¼ 8.9 Hz, 8.0
Hz, 1H), 4.67 (dd, J ¼ 9.0 Hz, 7.9 Hz, 1H), 7.16–7.27 (m, 2H),
7.27–7.33 (m, 1H), 7.33–7.34 (m, 2H). 13C NMR (75 MHz, CDCl3):
d/ppm 35.7, 41.1, 74.0, 126.7, 127.7, 129.1, 139.4, 176.3.
3-Butyl-g-butyrolactone.18 (1H NMR, 300 MHz, CDCl3, TMS): d/
ppm 0.92 (t, J ¼ 6.9 Hz, 3H), 1.15–1.30 (m, 4H), 1.43–1.52 (m,
2H), 2.14–2.33 (m, 2H), 2.49–2.66 (m, 2H), 3.89–3.95 (m, 1H),
4.39–4.44 (m, 1H). 13C-NMR (75 MHz, CDCl3): d/ppm 13.8, 22.4,
29.4, 32.7, 34.4, 35.6, 73.3, 177.2.
Isopropyl propanoate.25 (1H NMR, 600 MHz, CDCl3, TMS): d/
ppm 1.11 (t, J ¼ 7.6 Hz, 3H), 1.22 (d, J ¼ 6.3 Hz, 6H), 2.28 (q, J ¼
7.6 Hz, 2H), 5.00 (dt, J ¼ 12.5, 6.2 Hz, 1H). 13C NMR (150 MHz,
CDCl3): d/ppm 9.11, 21.78, 27.93, 67.45, 176.11–174.37.
p-Methoxyphenyl acetate.26 (1H NMR, 600 MHz, CDCl3, TMS):
d/ppm 2.28 (s, 2H), 3.79 (s, 2H), 6.89 (d, J ¼ 9.1 Hz, 1H), 7.00 (d, J
¼ 9.1 Hz, 1H). 13C NMR (150 MHz, CDCl3): d/ppm 21.02, 55.55,
114.44, 122.28, 144.17, 157.23, 169.87.
g-Butyrolactone.20 (1H-NMR, 300 MHz, CDCl3, TMS): d/ppm
2.13–2.24 (m, 2H), 2.38–2.44 (m, 2H), 4.27 (t, J ¼ 7.4 Hz, 2H).
13C-NMR (75 MHz, CDCl3): d/ppm 22.3, 28.0, 68.8, 178.1.
4-Oxatricyclo[4.3.1.13.8]undecan-5-one.20 (1H-NMR, 300 MHz,
CDCl3, TMS): d/ppm 1.70–2.15 (m, 12H), 3.01–3.12 (m, 1H),
4.39–4.52 (m, 1H). 13C NMR (75 MHz, CDCl3): d/ppm 25.8, 30.9,
33.7, 35.7, 41.2, 73.1, 178.2.
Results and discussion
Screening of metal chlorides
Metal chlorides were used as Lewis acidic catalysts in a model
oxidation of 2-adamantanone (Scheme 1) with a two-fold molar
excess of H2O2 (30% aq.), at 10 mol% metal chloride loading.
2-Oxabicyclo[3.2.1]octan-3-one.20 (1H-NMR, 300 MHz, CDCl3,
TMS): d/ppm 1.65–2.25 (m, 7H), 2.40–2.80 (m, 2H), 4.82–4.89
(m, 1H). 13C NMR (75 MHz, CDCl3): d/ppm 29.1, 31.7, 32.4, 35.7,
40.5, 80.9, 170.7.
3-Caprolactone.20 (1H-NMR, 600 MHz, CDCl3, TMS): d/ppm
1.72–1.87 (m, 4H), 1.88 (dd, J ¼ 5.3 Hz, 2.6 Hz, 2H), 2.62–2.67
Scheme 1 Model Baeyer–Villiger oxidation of 2-adamantanone.
30462 | RSC Adv., 2016, 6, 30460–30467
This journal is © The Royal Society of Chemistry 2016